Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TV003 vaccine protective efficacy against DENV-2 challenge
NCT02021968Phase 1Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2013
- Primary completion
- Mar 2015
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Butantan-DV in dengue fever, sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2013; status: completed.
02
Drugs
Butantan-DV
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT02021968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02021968.